ONO Pharmaceutical Co - Articles and news items

Celyad and ONO strike deal for NKR-2 in Japan, Korea and Taiwan

Industry news / 11 July 2016 / Victoria White, Digital Content Producer

This license agreement opens new markets to Celyad and expands the global footprint of its NKR-2 T-cell cancer immunotherapy treatment…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+